(Q40234004)

English

Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression

scientific article published on 7 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Gyoung Nyoun Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

C Yong Kang

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

7 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

357

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

41-53

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Defective translational control facilitates vesicular stomatitis virus oncolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Serological relationships between different strains of vesicular stomatis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Genetic evidence for multiple functions of the matrix protein of vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Role of nucleoporin induction in releasing an mRNA nuclear export block

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Complete nucleotide sequence of the matrix protein mRNA of vesicular stomatitis virus (New Jersey serotype).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Utilization of homotypic and heterotypic proteins of vesicular stomatitis virus by defective interfering particle genomes for RNA replication and virion assembly: implications for the mechanism of homologous viral interference

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Replication and transcription of viral RNAs by recombinant L proteins of New Jersey serotype of vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

The Cell-Rounding Activity of the Vesicular Stomatitis Virus Matrix Protein Is due to the Induction of Cell Death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Interaction between tubulin and the viral matrix protein of vesicular stomatitis virus: possible implications in the viral cytopathic effect

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Infectious defective interfering particles of VSV from transcripts of a cDNA clone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Multiple vesiculoviral matrix proteins inhibit both nuclear export and import

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Sequential disassembly of the cytoskeleton in BHK21 cells infected with vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Posttranscriptional regulation of hsp70 expression in human cells: effects of heat shock, inhibition of protein synthesis, and adenovirus infection on translation and mRNA stability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of matrix protein in cytopathogenesis of vesicular stomatitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Nucleotide sequence of a cDNA clone encoding the entire glycoprotein from the New Jersey serotype of vesicular stomatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative inhibition of cellular transcription by vesicular stomatitis virus serotypes New Jersey and Indiana: role of each viral leader RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

based on heuristic

inferred from DOI database lookup

N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2006.07.022

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40234004&oldid=1889672136"